Search results
20 cze 2024 · Klein and colleagues show that low-dose COVID-19 vaccination prevents breakthrough infection-mediated hippocampal dysfunction and cognitive memory decline in mouse models.
11 gru 2023 · Neuromuscular diseases (NMD) emerged as one of the main side effects of the COVID-19 vaccination. We pooled and summarized the evidence on the clinical features and outcomes of NMD associated with COVID-19 vaccination.
25 cze 2024 · Neurological post-acute sequelae of COVID-19 (neuroPASC) may be prevented by vaccination against SARS-CoV-2, even when other symptoms develop (breakthrough infection). Mechanisms underlying...
4 gru 2023 · In this Review, special emphasis is put on recently published multi-omics data that reveal dysregulation of CNS-resident cells in COVID-19 using gene transcription and protein profiling; this...
9 lut 2021 · In summary, it is expected that the content covered in this article help to understand the pathophysiology of COVID-19 and the impact on neuronal complications induced by SARS-CoV-2 infection while providing an update on the vaccine development. Keywords: SARS-CoV-2, Neurological damage, Coagulation, ACE-2, S-protein, Vaccine. Go to: Introduction.
1 lut 2024 · Yang et al. now show that human stem-cell-derived dopaminergic neurons are susceptible to SARS-CoV-2, triggering inflammation and senescence. The study further identifies three FDA-approved drugs capable of reversing these cellular phenotypes.
The data indicated an association between Ad26.COV2.S and an increased risk of GBS (observed-to-expected [OE] ratio at 21 days, 3.79; 95% CI, 2.88-4.88; OE ratio at 42 days, 2.34; 95% CI, 1.83-2.94), which was not observed for the mRNA vaccines (OE ratio less than 1 for both mRNA vaccines).11.
